Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.

Autor: Panka DJ; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. dpanka@bidmc.harvard.edu.; 330 Brookline Avenue, RW-571, Boston, MA, 02215, USA. dpanka@bidmc.harvard.edu., Liu Q; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.; Division of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Geissler AK; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.; 330 Brookline Avenue, RW-571, Boston, MA, 02215, USA., Mier JW; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.; 330 Brookline Avenue, RW-563A, Boston, MA, 02215, USA.
Jazyk: angličtina
Zdroj: Molecular cancer [Mol Cancer] 2021 Jun 11; Vol. 20 (1), pp. 89. Date of Electronic Publication: 2021 Jun 11.
DOI: 10.1186/s12943-021-01379-7
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje